Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in Human Liver Cells and Association with Hepatocellular Carcinoma

Toxicogenomics and Cancer Susceptibility: Advances with Next-Generation Sequencing

(2014) Baitang Ning et al.   JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS

Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters

(2014) Lun Yang et al.   PLoS One

miR-128 and its target genes in tumorigenesis and metastasis

(2013) Molin Li et al.   EXPERIMENTAL CELL RESEARCH

microRNAs as Mediators of Drug Toxicity

(2012) Tsuyoshi Yokoi et al.   Annual Review of Pharmacology and Toxicology

Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway

(2012) T Palumbo et al.   ONCOGENE

Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk

(2011) Liming Huang et al.   CARCINOGENESIS

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

(2011) S Donzelli et al.   CELL DEATH AND DIFFERENTIATION

Practical Aspects of microRNA Target Prediction

(2011) T. M. Witkos et al.   CURRENT MOLECULAR MEDICINE

Aberrant microRNA expression in human cervical carcinomas

(2011) Qunxian Rao et al.   MEDICAL ONCOLOGY

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS

(2011) Bin Xu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

MicroRNA expression profiles in the progression of prostate cancer—from high-grade prostate intraepithelial neoplasia to metastasis

(2011) Katia R.M. Leite et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

(2010) Wen Gao et al.   BIOMEDICINE & PHARMACOTHERAPY

Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes

(2010) L. Guo et al.   DRUG METABOLISM AND DISPOSITION

Functional Genetic Variants in the 3′-Untranslated Region of Sulfotransferase Isoform 1A1 (SULT1A1) and Their Effect on Enzymatic Activity

(2010) Xinfeng Yu et al.   TOXICOLOGICAL SCIENCES

Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer

(2009) Amjad P. Khan et al.   MOLECULAR & CELLULAR PROTEOMICS

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal

(2008) J. Godlewski et al.   CANCER RESEARCH